I would still want to know the interest rate that KML is paying on the loans. Until we have a handle on that we still probably have problems.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025